Ingredients: Analysis of active ingredients, intermediates, and excipients in pharmaceutical development and manufacturing - Pharmaceutical Technology

Latest Issue
PharmTech

Latest Issue
PharmTech Europe

Ingredients
Trends, market analysis, and market growth reports on pharmaceutical ingredient suppliers and manufacturers. Sourcing and supply of active pharmaceutical ingredients (APIs), intermediates, excipients.

QbD in API Manufacturing

September 2, 2014

Pharmaceutical Technology

With a quality-by-design approach, robust processes consistently can help deliver quality product.

Asymmetric Synthesis Continues to Advance

September 2, 2014

Pharmaceutical Technology

A survey of the recent literature reveals numerous advances in asymmetric chemocatalysis.

Meeting the Challenges of Excipient Variability

September 1, 2014

Pharmaceutical Technology

The quality and composition of excipients can vary due to environmental factors, processing methods, raw material quality, manufacturing location changes, and even operator actions.

Exploring a New Approval Process for Continued Excipient Innovation

September 1, 2014

Pharmaceutical Technology

New excipients and improvements to existing excipients are needed to facilitate access to new drugs for patients.

API Developers Pass Inspections and Upgrade Capabilities

September 1, 2014

Pharmaceutical Technology

API development and manufacturing companies expanded their capabilities, built partnerships, and achieved milestones in regulatory inspections.

Taking Action on Elemental Impurities

September 1, 2014

Pharmaceutical Technology

Changing regulations are impacting the identification and monitoring of variable materials in excipients.

Fast Locator 2014-2015 Index

August 18, 2014

View companies' outsourcing profiles from PharmTech's 2014 Outsourcing Resources Fast Locator Index in the following categories.

Risk Reduction Top Driver for Biopharmaceutical Raw Material Development

August 2, 2014

Pharmaceutical Technology

Customers are looking to reduce risk, increase performance, and optimize productivity.

Supply-Chain Security of Pharmaceutical Starting Materials

August 1, 2014

Pharmaceutical Technology Europe

IPEC Europe continues to promote the quality, safety and functionality of excipients used in pharmaceutical products.

ADVERTISEMENT

LCGC E-mail Newsletters

Subscribe: Click to learn more about the newsletter
| Weekly
| Monthly
|Monthly
| Weekly

Survey
FDASIA was signed into law two years ago. Where has the most progress been made in implementation?
Reducing drug shortages
Breakthrough designations
Protecting the supply chain
Expedited reviews of drug submissions
More stakeholder involvement
Reducing drug shortages
70%
Breakthrough designations
4%
Protecting the supply chain
17%
Expedited reviews of drug submissions
2%
More stakeholder involvement
7%
View Results
Eric Langerr Outsourcing Outlook Eric LangerTargeting Different Off-Shore Destinations
Cynthia Challener, PhD Ingredients Insider Cynthia ChallenerAsymmetric Synthesis Continues to Advance
Jill Wechsler Regulatory Watch Jill Wechsler Data Integrity Key to GMP Compliance
Sean Milmo European Regulatory WatchSean MilmoExtending the Scope of Pharmacovigilance Comes at a Price
Click here